151 related articles for article (PubMed ID: 7139191)
1. Competitive inhibition by adenosine 5'-triphosphate of the actions on human platelets of 2-chloroadenosine 5'-diphosphate, 2-azidoadenosine 5'-diphosphate and 2-methylthioadenosine 5'-diphosphate.
Cusack NJ; Hourani SM
Br J Pharmacol; 1982 Oct; 77(2):329-33. PubMed ID: 7139191
[TBL] [Abstract][Full Text] [Related]
2. Effects of analogues of adenine nucleotides on increases in intracellular calcium mediated by P2T-purinoceptors on human blood platelets.
Hall DA; Hourani SM
Br J Pharmacol; 1993 Mar; 108(3):728-33. PubMed ID: 8467360
[TBL] [Abstract][Full Text] [Related]
3. Adenosine 5-diphosphate antagonists and human platelets: no evidence that aggregation and inhibition of stimulated adenylate cyclase are mediated by different receptors.
Cusack NJ; Hourani SM
Br J Pharmacol; 1982 May; 76(1):221-7. PubMed ID: 6282375
[TBL] [Abstract][Full Text] [Related]
4. Benzoyl ATP is an antagonist of rat and human P2Y1 receptors and of platelet aggregation.
Vigne P; Hechler B; Gachet C; Breittmayer JP; Frelin C
Biochem Biophys Res Commun; 1999 Mar; 256(1):94-7. PubMed ID: 10066429
[TBL] [Abstract][Full Text] [Related]
5. Effects of RP and SP diastereoisomers of adenosine 5'-O-(1-thiodiphosphate) on human platelets.
Cusack NJ; Hourani SM
Br J Pharmacol; 1981 Jun; 73(2):409-12. PubMed ID: 7236993
[TBL] [Abstract][Full Text] [Related]
6. 2-Methylthioadenosine[beta-32P]diphosphate. An agonist and radioligand for the receptor that inhibits the accumulation of cyclic AMP in intact blood platelets.
Macfarlane DE; Srivastava PC; Mills DC
J Clin Invest; 1983 Mar; 71(3):420-8. PubMed ID: 6298277
[TBL] [Abstract][Full Text] [Related]
7. Specific but noncompetitive inhibition by 2-alkylthio analogues of adenosine 5'-monophosphate and adenosine 5'-triphosphate of human platelet aggregation induced by adenosine 5'-diphosphate.
Cusack NJ; Hourani SM
Br J Pharmacol; 1982 Feb; 75(2):397-400. PubMed ID: 7186826
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of adenine nucleotide analogues on shape change and aggregation induced by adnosine 5-diphosphate (ADP) in human platelets.
Park HS; Hourani SM
Br J Pharmacol; 1999 Jul; 127(6):1359-66. PubMed ID: 10455285
[TBL] [Abstract][Full Text] [Related]
9. Differential inhibition by adenosine or by prostaglandin E1 of human platelet aggregation induced by adenosine 5'-O-(1-thiodiphosphate) and adenosine 5'-O-(2-thiodiphosphate).
Cusack NJ; Hourani SM
Br J Pharmacol; 1982 Feb; 75(2):257-9. PubMed ID: 6892270
[TBL] [Abstract][Full Text] [Related]
10. Partial agonist behaviour of adenosine 5'-O-(2-thiodiphosphate) on human platelets.
Cusack NJ; Hourani SM
Br J Pharmacol; 1981 Jun; 73(2):405-8. PubMed ID: 7236992
[TBL] [Abstract][Full Text] [Related]
11. Effects of suramin on increases in cytosolic calcium and on inhibition of adenylate cyclase induced by adenosine 5'-diphosphate in human platelets.
Hall DA; Hourani SM
Biochem Pharmacol; 1994 Mar; 47(6):1013-8. PubMed ID: 8147900
[TBL] [Abstract][Full Text] [Related]
12. Two mechanisms for inhibition of ADP-induced platelet shape change by 5'-p-fluorosulfonylbenzoyladenosine. Conversion to adenosine, and covalent modification at an ADP binding site distinct from that which inhibits adenylate cyclase.
Mills DC; Figures WR; Scearce LM; Stewart GJ; Colman RF; Colman RW
J Biol Chem; 1985 Jul; 260(13):8078-83. PubMed ID: 2989276
[TBL] [Abstract][Full Text] [Related]
13. Identification of a receptor for ADP on blood platelets by photoaffinity labelling.
Cristalli G; Mills DC
Biochem J; 1993 May; 291 ( Pt 3)(Pt 3):875-81. PubMed ID: 8387782
[TBL] [Abstract][Full Text] [Related]
14. Clopidogrel inhibits the binding of ADP analogues to the receptor mediating inhibition of platelet adenylate cyclase.
Mills DC; Puri R; Hu CJ; Minniti C; Grana G; Freedman MD; Colman RF; Colman RW
Arterioscler Thromb; 1992 Apr; 12(4):430-6. PubMed ID: 1558834
[TBL] [Abstract][Full Text] [Related]
15. Inhibition by a stable analogue of adenosine triphosphate of platelet aggregation by adenosine diphosphate.
Born GV; Foulks JG
Br J Pharmacol; 1977 Sep; 61(1):87-9. PubMed ID: 912211
[TBL] [Abstract][Full Text] [Related]
16. Effects of the P2-purinoceptor antagonist, suramin, on human platelet aggregation induced by adenosine 5'-diphosphate.
Hourani SM; Hall DA; Nieman CJ
Br J Pharmacol; 1992 Feb; 105(2):453-7. PubMed ID: 1559134
[TBL] [Abstract][Full Text] [Related]
17. Interaction of human blood platelets with the 2',3'-dialdehyde and 2',3'-dialcohol derivatives of adenosine 5'-diphosphate and adenosine 5'-triphosphate.
Pearce PH; Wright JM; Egan CM; Scrutton MC
Eur J Biochem; 1978 Aug; 88(2):543-54. PubMed ID: 689037
[TBL] [Abstract][Full Text] [Related]
18. Binding of 2-azidoadenosine [beta-32P]diphosphate to the receptor on intact human blood platelets which inhibits adenylate cyclase.
Macfarlane DE; Mills DC; Srivastava PC
Biochemistry; 1982 Feb; 21(3):544-9. PubMed ID: 6279146
[No Abstract] [Full Text] [Related]
19. Effects of extracellular divalent cations on responses of human blood platelets to adenosine 5'-diphosphate.
Hall DA; Frost V; Hourani SM
Biochem Pharmacol; 1994 Oct; 48(7):1319-26. PubMed ID: 7945429
[TBL] [Abstract][Full Text] [Related]
20. Nucleoside triphosphates inhibit ADP, collagen, and epinephrine-induced platelet aggregation: role of P2Y₁ and P2Y₁₂ receptors.
Aslam M; Sedding D; Koshty A; Santoso S; Schulz R; Hamm C; Gündüz D
Thromb Res; 2013 Nov; 132(5):548-57. PubMed ID: 24071464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
